Re: Either 17yrs from issue date or 20yrs from the filing date priority is claimed

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Either 17yrs from issue date or 20yrs from the filing date priority is claimed

in response to

Either 17yrs from issue date or 20yrs from the filing date priority is claimed

MIKE6553

posted on Jul 04, 2012 05:02PM

What you posted applies to all the MMP patents, but not the 148. The 148 filing date is 7/29/98, therefore this applies.

CONTINUING APPLICATIONS

A patent granted on a continuation, divisional, or continuation-in-part application that was filed on or after June 8, 1995, will have a term which ends twenty years from the filing date of earliest application for which a benefit is claimed

It was a normal expiration since the 148, claimed the benefit of the 8/3/89 filing date of the parent application.